MassMutual Private Wealth & Trust’s Immunovant IMVT Stock Holding History
Bought
Maintained
Sold
Other funds holding IMVT
MassMutual Private Wealth & Trust's IMVT Position: Q3 2026 in Review
MassMutual Private Wealth & Trust reduced its Immunovant (IMVT) stake by 49% in Q3 2026, selling an estimated $3.59K and leaving 93 shares worth $3.14K. The position accounts for ﹤0.01% of the portfolio, ranked #1789.
MassMutual Private Wealth & Trust first reported a position in IMVT in Q1 2021 and has held it in 8 quarters since. The position peaked at $7.09K in Q2 2026. 223 funds tracked by Wall St. Rank hold IMVT as of Q3 2026.
- MassMutual Private Wealth & Trust held 93 shares of Immunovant worth $3.14K as of Q3 2026.
- MassMutual Private Wealth & Trust sold 91 Immunovant shares in Q3 2026, an estimated $3.59K.
- Immunovant made up ﹤0.01% of MassMutual Private Wealth & Trust's portfolio in Q3 2026, its #1789 holding.
- MassMutual Private Wealth & Trust first reported a position in Immunovant in Q1 2021 and has held it in 8 quarters since.
- MassMutual Private Wealth & Trust's Immunovant position peaked at $7.09K in Q2 2026.
- 223 funds tracked by Wall St. Rank held Immunovant as of Q3 2026.
Based on MassMutual Private Wealth & Trust's 13F filing for Q3 2026, filed 5 Oct 2026.